Want to join the conversation?
$WDFC lifted its FY16 EPS guidance to range of $3.40-3.47 from previous forecast of $3.30-3.37. This EPS forecast is based on an estimated 14.4MM weighted average shares outstanding. $WDFC lowered its FY16 net sales outlook to $385-394MM from previous estimate of $393-401MM and net sales growth forecast to 2-4% from prior estimate of 4-6%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?